• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ATDC

ATDC

Menu
  • About
    • Impact
    • Team
    • Sponsors & Partners
    • Mentors
    • Contact Us
    • Locations
      • ATDC HQ (Midtown Atlanta)
      • ATDC @ ALPHARETTA
      • ATDC @ ATHENS
      • ATDC @ AUGUSTA
      • ATDC @ FORSYTH COUNTY
      • ATDC @ PEACHTREE CORNERS
      • ATDC @ SAVANNAH
  • How We Help
    • Overview
    • Classes
    • Capital
    • Customers
    • Georgia Tech Resources
  • Portfolio
    • Overview
    • Criteria
    • ATDC Accelerate
    • ATDC Signature
    • Graduates
    • Testimonials
  • Industry Vertical Markets
    • 5G
  • Events
  • News + Jobs
    • News
    • ATDC Company Job Board
  • Login
  • Join

National Cancer Institute Solicits SBIR Phase II Bridge Funding Applications

February 21, 2011 by ei2admin

The National Cancer Institute, a part of the National Institutes of Health, announced release of the 2011 Phase II Bridge Award program.  The grant will bridge the funding gap, or “valley of death”, between SBIR Phase II and Phase III projects and must be matched by third party investors.

As many as ten grants of up to $1 million per year for up to three years will awarded in 2011.  Development efforts may include preclinical R&D or clinical trials in three project areas:

(1) cancer therapeutics

(2) cancer imaging technologies, interventional devices and in vivo diagnostics

(3) in vitro and ex vivo cancer diagnostics and prognostics

Complete information can be found on the National Cancer Institute’s SBIR announcements website.

To apply for the SBIR Phase II Bridge Award, a letter of intent must be submitted by March 7, 2011.  Full applications are due by April 7.

Category iconSBIR/STTR News

What is ATDC?

Footer

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

© Copyright 1986 - 2023. Advanced Technology Development Center.
All Rights Reserved.
Tech Square  |  75 5th Street NW, Suite 2000  |  Atlanta, GA 30308
t: (404) 894-3575  |  f: (404) 894-4545 Terms of Use | Contact Us